Jonatan Salzer

3.2k total citations · 1 hit paper
49 papers, 2.1k citations indexed

About

Jonatan Salzer is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Jonatan Salzer has authored 49 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pathology and Forensic Medicine, 15 papers in Neurology and 15 papers in Oncology. Recurrent topics in Jonatan Salzer's work include Multiple Sclerosis Research Studies (27 papers), Polyomavirus and related diseases (13 papers) and Peripheral Neuropathies and Disorders (9 papers). Jonatan Salzer is often cited by papers focused on Multiple Sclerosis Research Studies (27 papers), Polyomavirus and related diseases (13 papers) and Peripheral Neuropathies and Disorders (9 papers). Jonatan Salzer collaborates with scholars based in Sweden, United States and Germany. Jonatan Salzer's co-authors include Anders Svenningsson, Peter Sundström, Fredrik Piehl, Jan Lycke, Thomas Frisell, Katharina Fink, Peter Alping, Hans Stenlund, Maria Nyström and Göran Hallmans and has published in prestigious journals such as Brain, Neurology and Annals of Neurology.

In The Last Decade

Jonatan Salzer

49 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

2019 346 citations Peter Alping, Joachim Burman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonatan Salzer Sweden	21	1.6k	638	537	490	258	49	2.1k
Mónica Marta United Kingdom	20	1.0k 0.7×	368 0.6×	761 1.4×	487 1.0×	266 1.0×	66	1.9k
Joël Oger Canada	31	1.4k 0.9×	1.1k 1.8×	339 0.6×	443 0.9×	484 1.9×	72	2.7k
Amanda Cox United States	18	809 0.5×	470 0.7×	564 1.1×	316 0.6×	225 0.9×	45	1.8k
Hirofumi Ochi Japan	24	654 0.4×	468 0.7×	649 1.2×	194 0.4×	303 1.2×	89	1.8k
Marina Rode von Essen Denmark	23	909 0.6×	151 0.2×	834 1.6×	281 0.6×	93 0.4×	62	1.9k
Antonios Bayas Germany	19	459 0.3×	224 0.4×	301 0.6×	210 0.4×	101 0.4×	52	1.2k
K. P. Johnson United States	8	882 0.6×	363 0.6×	589 1.1×	365 0.7×	356 1.4×	12	1.6k
Claire Hirst United Kingdom	15	900 0.6×	374 0.6×	238 0.4×	189 0.4×	267 1.0×	27	1.2k
Carolina Ionete United States	16	495 0.3×	251 0.4×	277 0.5×	151 0.3×	144 0.6×	51	1.3k
Peter Hjelmström Sweden	23	372 0.2×	207 0.3×	1.3k 2.4×	446 0.9×	288 1.1×	46	2.4k

Countries citing papers authored by Jonatan Salzer

Since Specialization

Citations

This map shows the geographic impact of Jonatan Salzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonatan Salzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonatan Salzer more than expected).

Fields of papers citing papers by Jonatan Salzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonatan Salzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonatan Salzer. The network helps show where Jonatan Salzer may publish in the future.

Co-authorship network of co-authors of Jonatan Salzer

This figure shows the co-authorship network connecting the top 25 collaborators of Jonatan Salzer. A scholar is included among the top collaborators of Jonatan Salzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonatan Salzer. Jonatan Salzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Breu, Markus, Ruxandra‐Iulia Milos, J Svoboda, et al.. (2024). Rituximab treatment in pediatric‐onset multiple sclerosis. European Journal of Neurology. 31(5). e16228–e16228. 12 indexed citations

Piehl, Fredrik, Peter Alping, Simon Englund, et al.. (2024). COMBAT‐MS: A Population‐Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab. Annals of Neurology. 96(4). 678–693. 3 indexed citations

Evertsson, Björn, Pierre de Flon, Yunzhang Wang, et al.. (2024). Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study. European Journal of Neurology. 31(8). e16331–e16331. 4 indexed citations

Biström, Martin, Jonatan Salzer, Pernilla Stridh, et al.. (2023). Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis. Brain. 147(1). 177–185. 13 indexed citations

Eriksson, Marie, et al.. (2023). Characteristics of in-hospital stroke patients in Sweden: A nationwide register-based study. European Stroke Journal. 8(3). 777–783. 5 indexed citations

Longinetti, Elisa, Simon Englund, Joachim Burman, et al.. (2023). Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy. Journal of Neurology Neurosurgery & Psychiatry. 95(2). 134–141. 7 indexed citations

Englund, Simon, Marie Kierkegaard, Joachim Burman, et al.. (2022). Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort. Multiple Sclerosis and Related Disorders. 70. 104481–104481. 9 indexed citations

Grip, Helena, Fredrik Öhberg, Torbjörn Ledin, et al.. (2022). Internet-based vestibular rehabilitation versus standard care after acute onset vertigo: a study protocol for a randomized controlled trial. Trials. 23(1). 496–496. 2 indexed citations

Ryška, Pavel, et al.. (2021). Variability of Normal Pressure Hydrocephalus Imaging Biomarkers with Respect to Section Plane Angulation: How Wrong a Radiologist Can Be?. American Journal of Neuroradiology. 42(7). 1201–1207. 9 indexed citations

10.

Sundström, Peter, et al.. (2021). Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis. Journal of Neurology. 268(6). 2161–2168. 33 indexed citations

11.

Ghezzi, Angelo, Brenda Banwell, Amit Bar‐Or, et al.. (2020). Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations. Multiple Sclerosis Journal. 27(12). 1814–1822. 22 indexed citations

12.

Hansson, Anders & Jonatan Salzer. (2020). Normative video head impulse test data in subjects with and without vascular risk factors. European Archives of Oto-Rhino-Laryngology. 278(7). 2619–2624. 8 indexed citations

13.

Axelsson, Markus, Lenka Novakova, Thomas Frisell, et al.. (2019). Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis. European Journal of Neurology. 26(8). 1060–1067. 26 indexed citations

14.

Evertsson, Björn, F. Johansson, Jan Lycke, et al.. (2019). Risk of hypogammaglobulinemia in long-term treatment with rituximab in multiple sclerosis. Multiple Sclerosis Journal. 25. 20–20. 10 indexed citations

15.

Granåsen, Gabriel, et al.. (2019). Effectiveness of care in acute dizziness presentations. European Archives of Oto-Rhino-Laryngology. 276(9). 2389–2396. 3 indexed citations

16.

Ryška, Pavel, et al.. (2019). Radiological markers of idiopathic normal pressure hydrocephalus: Relative comparison of their diagnostic performance. Journal of the Neurological Sciences. 408. 116581–116581. 21 indexed citations

17.

Alping, Peter, Lenka Novakova, Jonatan Salzer, et al.. (2015). Superior efficacy and tolerability of rituximab as compared to fingolimod for MS patients switching from natalizumab due to positive JC virus serology. Multiple Sclerosis Journal. 21(11). 555–555. 2 indexed citations

18.

Salzer, Jonatan, Jan Lycke, Ronny Wickström, et al.. (2015). Rituximab in paediatric onset multiple sclerosis: a case series. Journal of Neurology. 263(2). 322–326. 46 indexed citations

19.

Salzer, Jonatan, Martin Biström, & Peter Sundström. (2013). Vitamin D and multiple sclerosis: where do we go from here?. Expert Review of Neurotherapeutics. 14(1). 9–18. 16 indexed citations

20.

Salzer, Jonatan, et al.. (2009). Season of birth and multiple sclerosis in Sweden. Acta Neurologica Scandinavica. 121(1). 20–23. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact